Status:
COMPLETED
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Bacteremia
Fungemia
Eligibility:
All Genders
Up to 99 years
Phase:
NA
Brief Summary
Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture b...
Detailed Description
We hypothesize that the FilmArray Blood Culture ID Panel will reduce the duration of empiric broad-spectrum antimicrobial therapy typically administered in patients who have positive blood cultures, i...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Positive blood culture during the study period.
- No positive blood cultures in prior 7 days
- Minnesota state research authorization provided
- Exclusion criteria:
- No Minnesota state research authorization
- Deceased or transitioned to comfort care within 24 hours of enrollment
- Positive blood culture in prior 7 days
- Previously enrolled in this study
- Negative Gram stain
Exclusion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
743 Patients enrolled
Trial Details
Trial ID
NCT01898208
Start Date
August 1 2013
End Date
August 1 2014
Last Update
March 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905